Sinopharm
1099.HK
#2239
Rank
โ‚ฌ7.06 B
Marketcap
2,26ย โ‚ฌ
Share price
1.58%
Change (1 day)
9.57%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2024: โ‚ฌ69.24 Billion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚ฌ69.24 Billion. In 2024 the company made a revenue of โ‚ฌ69.24 Billion a decrease over the revenue in the year 2023 that were of โ‚ฌ72.96 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2024

Annual revenue

Year Revenue Change
2024โ‚ฌ69.24 B-5.1%
2023โ‚ฌ72.96 B5.42%
2022โ‚ฌ69.21 B-2.1%
2021โ‚ฌ70.69 B16.85%
2020โ‚ฌ60.50 B14.95%
2019โ‚ฌ52.63 B21.52%
2018โ‚ฌ43.31 B5.93%
2017โ‚ฌ40.88 B27.22%
2016โ‚ฌ32.13 B5.37%
2015โ‚ฌ30.49 B9.14%
2014โ‚ฌ27.94 B17.22%
2013โ‚ฌ23.83 B25.94%
2012โ‚ฌ18.92 B34.61%
2011โ‚ฌ14.06 B55.34%
2010โ‚ฌ9.05 B35.79%
2009โ‚ฌ6.66 B37.56%
2008โ‚ฌ4.84 B31.43%
2007โ‚ฌ3.68 B40.26%
2006โ‚ฌ2.62 B